Campaign Story

BrainSightAI is a Bengaluru health-tech company applying AI to functional brain imaging to generate patient-specific connectome maps that support tumor planning, epilepsy workups, and psychiatric investigations. Their VoxelBox suite delivers surgeon/radiologist-ready reports from MRI and rs-fMRI, accelerating decision-making and aiming to improve outcomes.

The company, founded by Laina Emmanuel and Rimjhim Agrawal, achieved a key regulatory milestone in March 2024 with India’s CDSCO SaMD clearance, moving the product from research into clinical use. By early 2025, media reports noted collaborations with 40+ hospitals nationwide, reflecting growing clinical adoption.

Press coverage highlights BrainSightAI’s role in bringing AI connectomics into mainstream neurology and neurosurgery—positioning India as a hub for advanced neuro-diagnostics. Their Bengaluru address is publicly listed (HSR Layout), and the company maintains active outreach via its site and socials.